Abstract
Histone deacetylase inhibitor sodium butyrate (NaBu) can induce G0/G1 arrest and erythroid differentiation in K562 cells, but the molecular mechanisms underlying this process are unclear. Here we show that both p18INK4C mRNA and protein levels were upregulated during K562 cell erythroid differentiation induced by NaBu. Moreover, the NaBu activation of p18INK4C was dependent on the integrity of Sp1 clusters in the promoter. NaBu caused hyperacetylation of histones H3 and H4 on endogenous p18INK4C promoter and enhanced binding of transcription factor Sp1 in vivo. Also, overexpression of p18INK4C in K562 cells resulted in G0/G1 arrest and partial erythroid differentiation. Our results suggested that NaBu-mediated p18INK4C regulation played a role in cell cycle arrest and erythroid differentiation in K562 cells.
Similar content being viewed by others
Abbreviations
- CDK:
-
Cyclin-dependent kinase
- ChIP:
-
Chromatin immunoprecipitation
- CKI:
-
Cyclin-dependent kinase inhibitor
- HAT:
-
Histone acetyltransferase
- HDAC:
-
Histone deacetylase
- NaBu:
-
Sodium butyrate
References
Iyer NG, Ozdag H, Caldas C (2004) p300/CBP and cancer. Oncogene 23:4225–4231. doi:10.1038/sj.onc.1207118
Wolffe AP (2001) Chromatin remodeling: why it is important in cancer. Oncogene 20:2988–2990. doi:10.1038/sj.onc.1204322
Marks PA, Richon VM, Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92:1210–1216. doi:10.1093/jnci/92.15.1210
Chen B, Cepko CL (2007) Requirement of histone deacetylase activity for the expression of critical photoreceptor genes. BMC Dev Biol 7:78. doi:10.1186/1471-213X-7-78
Wu ZQ, Zhang R, Chao C et al (2007) Histone deacetylase inhibitor trichostatin A induced caspase-independent apoptosis in human gastric cancer cell. Chin Med J (Engl) 120:2112–2118
Takai N, Ueda T, Nishida M et al (2008) Histone deacetylase inhibitors induce growth inhibition, cell cycle arrest and apoptosis in human choriocarcinoma cells. Int J Mol Med 21:109–115
Budillon A, Di Gennaro E, Bruzzese F et al (2007) Histone deacetylase inhibitors: a new wave of molecular targeted anticancer agents. Recent Patents Anticancer Drug Discov 2:119–134
Witt O, Sand K, Pekrun A (2000) Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways. Blood 95:2391–2396
Cioe L, McNab A, Hubbell HR et al (1981) Differential expression of the globin genes in human leukemia K562(S) cells induced to differentiate by hemin or butyric acid. Cancer Res 41:237–243
Chen TH, Chen WM, Hsu KH et al (2007) Sodium butyrate activates ERK to regulate differentiation of mesenchymal stem cells. Biochem Biophys Res Commun 355:913–918. doi:10.1016/j.bbrc.2007.02.057
Andersson LC, Jokinen M, Gahmberg CG (1979) Induction of erythroid differentiation in the human leukaemia cell line K562. Nature 278:364–365. doi:10.1038/278364a0
Sherr CJ, Roberts JM (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev 18:2699–2711. doi:10.1101/gad.1256504
Sherr CJ, Roberts JM (1999) CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501–1512. doi:10.1101/gad.13.12.1501
Thullberg M, Bartkova J, Khan S et al (2000) Distinct versus redundant properties among members of the INK4 family of cyclin-dependent kinase inhibitors. FEBS Lett 470:161–166. doi:10.1016/S0014-5793(00)01307-7
Nakayama K, Nakayama K (1998) Cip/Kip cyclin-dependent kinase inhibitors: brakes of the cell cycle engine during development. Bioessays 20:1020–1029. doi:10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D
Lewis JL, Chinswangwatanakul W, Zheng B et al (2001) The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cells. Blood 97:2604–2610. doi:10.1182/blood.V97.9.2604
Munoz-Alonso MJ, Acosta JC, Richard C et al (2005) p21Cip1 and p27Kip1 induce distinct cell cycle effects and differentiation programs in myeloid leukemia cells. J Biol Chem 280:18120–18129. doi:10.1074/jbc.M500758200
Schrantz N, Beney GE, Auffredou MT et al (2000) The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation. J Immunol 165:4346–4352
Zindy F, Soares H, Herzog KH et al (1997) Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development. Cell Growth Differ 8:1139–1150
Gursky S, Olopade OI, Rowley JD (2001) Identification of a 1.2 Kb cDNA fragment from a region on 9p21 commonly deleted in multiple tumor types. Cancer Genet Cytogenet 129:93–101. doi:10.1016/S0165-4608(01)00444-7
Blais A, Monte D, Pouliot F et al (2002) Regulation of the human cyclin-dependent kinase inhibitor p18INK4c by the transcription factors E2F1 and Sp1. J Biol Chem 277:31679–31693. doi:10.1074/jbc.M204554200
Franklin DS, Xiong Y (1996) Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation. Mol Biol Cell 7:1587–1599
Van Lint C, Emiliani S, Verdin E (1996) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr 5:245–253
Cao H, Stamatoyannopoulos G, Jung M (2004) Induction of human gamma globin gene expression by histone deacetylase inhibitors. Blood 103:701–709. doi:10.1182/blood-2003-02-0478
Pestell RG, Albanese C, Reutens AT et al (1999) The cyclins and cyclin-dependent kinase inhibitors in hormonal regulation of proliferation and differentiation. Endocr Rev 20:501–534. doi:10.1210/er.20.4.501
Yokota T, Matsuzaki Y, Sakai T (2004) Trichostatin A activates p18INK4c gene: differential activation and cooperation with p19INK4d gene. FEBS Lett 574:171–175. doi:10.1016/j.febslet.2004.08.025
Rylski M, Welch JJ, Chen YY et al (2003) GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol 23:5031–5042. doi:10.1128/MCB.23.14.5031-5042.2003
Zhu Y, Lee HC, Zhang L (2002) An examination of heme action in gene expression: heme and heme deficiency affect the expression of diverse genes in erythroid k562 and neuronal PC12 cells. DNA Cell Biol 21:333–346. doi:10.1089/104454902753759744
Davie JR (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr 133:2485S–2493S
Yokota T, Matsuzaki Y, Miyazawa K et al (2004) Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter. Oncogene 23:5340–5349. doi:10.1038/sj.onc.1207689
Grunstein M (1997) Histone acetylation in chromatin structure and transcription. Nature 389:349–352. doi:10.1038/38664
Duan H, Heckman CA, Boxer LM (2005) Histone deacetylase inhibitors down-regulate bcl-2 expression and induce apoptosis in t(14;18) lymphomas. Mol Cell Biol 25:1608–1619. doi:10.1128/MCB.25.5.1608-1619.2005
Gemma A, Takenoshita S, Hagiwara K et al (1996) Molecular analysis of the cyclin-dependent kinase inhibitor genes p15INK4b/MTS2, p16INK4/MTS1, p18 and p19 in human cancer cell lines. Int J Cancer 68:605–611. doi:10.1002/(SICI)1097-0215(19961127)68:5<605::AID-IJC9>3.0.CO;2-2
Roussel MF (1999) The INK4 family of cell cycle inhibitors in cancer. Oncogene 18:5311–5317. doi:10.1038/sj.onc.1202998
Drexler HG (1998) Review of alterations of the cyclin-dependent kinase inhibitor INK4 family genes p15, p16, p18 and p19 in human leukemia-lymphoma cells. Leukemia 12:845–859. doi:10.1038/sj.leu.2401043
Acknowledgments
We thank Dr. Blais (Centre Hospitalier Universitaire de Quebec, Canada) for providing plasmids. This work was supported by grants from The National Basic Research Program of China (2005CB522404, 2006CB910506), the Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in Universities (IRT0519), and the National Natural Science Foundation of China (30771232, 30671184).
Author information
Authors and Affiliations
Corresponding author
Additional information
L. Li and G. Zhang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, L., Zhang, G., Zhang, Y. et al. Sodium butyrate-induced upregulation of p18INK4C gene affects K562 cell G0/G1 arrest and differentiation. Mol Cell Biochem 319, 9–15 (2008). https://doi.org/10.1007/s11010-008-9870-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-008-9870-x